|
SFDA issues the No.126 announcement of drug administrative protection
|
|
The State Food and Drug Administration (SFDA) issued the No.126 Drug Administrative Protection Announcement on January 17, 2008, declaring the ending of drug administrative protection for Novo Nordisk's NovoNorm (repaglinide) tablets.
| |
|
|
